Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis

Multiple Sclerosis

Volumn 4, Issue 3, 1998, Pages 203-211

  Stinissen, Piet ^a   Medaer, Robert ^a   Raus, Jef ^a  

^a HASSELT UNIVERSITY   (Belgium)

Author keywords

Autoimmunity; Autoreactive T cells; Immunotherapy; Multiple sclerosis; Myelin basic protein

Indexed keywords

MYELIN; MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; DEMYELINATION; DISEASE ACTIVITY; HUMAN; IMMUNOTHERAPY; INFLAMMATORY DISEASE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; T LYMPHOCYTE;

EID: 0031680514     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859800400322     Document Type: Article

References (70)

1. Zamvil SS, Steinman L. (1990) The T lymphocyte in experimental allergic encephalomyelitis. Ann Rev Immunol, 8: 579 - 621.
2. Martin R, McFarland HF. (1995) Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sc 32: 121 - 182.
3. Steinman L. (1996) Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system. Cell 85: 299 - 302.
4. Stinissen P, Raus J, Zhang J. (1997) Autoimmune pathogenesis of Multiple Sclerosis: Role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit Rev Immunol 17: 33 - 75.
5. Wucherpfennig KW, Strominger JL. (1995) Molecular mimicry in T cell mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80: 695 - 705.
6. Zhang J et al. (1995) Activation and clonal expansion of human myelin basic protein reactive T cells by bacterial superantigens. J Autoimmun 8: 615 - 632.
7. Brocke S et al. (1993) Induction of relapsing paralysis in experimental allergic encephalomyelitis by bacterial superantigens. Nature 365: 642 - 644.
8. Cohen IR. (1992) The cognitive paradigm and the immunological homunculus. Immunol Today 13: 490 - 494.
9. Hafler DA, Weiner HL. (1987) In vivo labeling of blood T cells: rapid traffic into cerebrospinal fluid in multiple sclerosis. Ann Neurol 22: 89 - 93.
10. Bauer J, Wekerle H, Lassmann H. (1995) Apoptosis in brain specific autoimmune disease. Curr Opin Immunol 7: 839 - 843.
11. Shrikant P, Benveniste EN. (1996) The central nervous system as an immunocompetent organ: Role of glial cells in antigen presentation. J Immunol 157: 1819 - 1822.
12. Navikas V, Link H. (1996) Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosc Res 45: 322 - 333.
13. Tuohy VK. (1994) Peptide determinants of myelin proteolipid protein (PLP) in autoinmune demyelinating disease: A review. Neurochem Res 19: 935 - 944.
14. Bernard CCA et al. (1997) Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med 75: 77 - 88.
15. Zhang JW et al. (1992) Myelin basic protein specific T lymphocytes: precursor frequency, fine specificity and cytotoxicity. Ann Neurol 32: 330 - 338.
16. Kuchroo VK et al. (1993) Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 151: 4371 - 4382.
17. Zhang J et al. (1994) Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179: 973 - 984.
18. Chou YK et al. (1992) Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 38: 105 - 113.
19. Allegretta M, Nicklas JA, Sriram S, Albertini RJ. (1990) T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247: 718 - 721.
20. Vandevyver C et al. (1995) Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur J Immunol 25: 958 - 968.
21. Hafler DA et al (1996) TCR usage in human and experimental demyelinating disease. Immunol Today 17: 152 - 159.
22. Martin R et al. (1990) Fine specificity and HLA restriction of myelin basic protein reactive cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol 145: 540 - 548.
23. Valli A et al. (1993) Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest 91: 616 - 628.
24. Ando DG et al. (1989) Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol 124: 132 - 134.
25. Hermans G et al. (1997) Cytokine profile of myelin basic protein reactive T cells in multiple sclerosis and healthy individuals. Ann Neurol 42: 18 - 27.
26. Hemmer B et al. (1996) Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99). J Neurosc Res 45: 852 - 862.
27. Oksenberg JM et al. (1993) Selection for T cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in the brain lesions of multiple sclerosis. Nature 362: 68 - 73.
28. Genain CP, Hauser SL. (1997) Creation of a model for multiple sclerosis in Callithrix jacchus marmosets. J Mol Med 75: 187 - 197.
29. Meinl E et al. (1997) Encephalitogenic potential of myelin basic protein specific T cells isolated from normal Rhesus Macaques. Am J Pathol 150: 445 - 453.
30. Linington C et al. (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130: 443 - 454.
31. Kerlero de Rosbo N et al. (1993) Reactivity to myelin antigens in Multiple sclerosis: Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest 92: 2602 - 2608.
32. Kuchroo V et al. (1992) Experimental allergic encepha-lomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V beta gene usage. J Immunol 148: 3776 - 3782.
33. Lehman PV et al. (1993) Determinant spreading and the dynamics of the autoinimune T cell repertoire. Immunol Today 14: 203 - 208.
34. Wucherpfennig KW et al. (1994) Clonal expansion and persistence of human T cells specific for an immunodo-minant myelin basic protein peptide. J Immunol 152: 5581 - 5592.
35. Salvetti M et al. (1993) Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis. Eur J Immunol 23: 1232 - 1239.
36. Meinl E et al. (1993) Myelin basic protein specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to the recruitment of multiple T cell clones. J Clin Invest 92: 2633 - 2644.
37. Ebers GC. (1994) Treatment of multiple sclerosis. Lancet 343: 275 - 279.
38. IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group. (1995) Interferon beta-Ib in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurol 45: 1277 - 1285.
39. Johnson KP et al. (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind, placebo-controlled trial. Neurol 45:1268 - 1276.
40. Jacobs LD et al. (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 39: 285 - 294.
41. Weiner HL. (1997) Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 18: 335 - 343.
42. Weiner HL et al. (1993) Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259: 1321 - 1326.
43. Brocke S et al. (1996) Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379: 343 - 346.
44. Windhagen A et al. (1995) Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2: 373 - 380.
45. Karin N et al. (1994) Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production. J Exp Med 180: 2227 - 2237.
46. Gaur A et al. (1997) Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms. J Neuroimmunol 74: 149 - 158.
47. Vergelli M et al. (1997) Modifications of peptide ligands enhancing T cell responsiveness imply large number of stimulatory ligands for autoreactive T cells. J Immunol 158: 3746 - 3752.
48. Ben-Nun A, Wekerle H, Cohen IR. (1981) Vaccination against autoimmune encephalomyelitis with T lymphocyte line cells reactive against myelin basic protein. Nature 292: 60 - 61.
49. Zhang J et al. (1993) MHC restricted clonotypic depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 261: 1451 - 1454.
50. Medaer R et al. (1995) Depletion of myelin-basic protein autoreactive T cells by T cell vaccination: pilot trial in multiple sclerosis. Lancet 346: 807 - 808.
51. Zhang J, Vandevyver C, Stinissen P, Raus J. (1995) In vivo clonotypic regulation of human myelin basic protein reactive T cells by T cell vaccination. J Immunol 155: 5868 - 5877.
52. Stinissen P et al. (1996) Vaccination with autoreactive T cell clones in multiple sclerosis: Overview of immuno-logical and clinical data. J Neurosc Res 45: 500 - 511.
53. Vandenbark AA, Hashim GA, Offner H. (1989) Immunization with a synthetic T cell receptor V region peptide protects against experimental autoimmune encephalomyelitis. Nature 341: 541 - 544.
54. Howell MD et al. (1989) Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246: 668 - 670.
55. Vandenbark AA et al. (1996) Treatment of multiple sclerosis with T cell receptor peptides: results of a double blind pilot trial. Nature Med 2: 1109 - 1115.
56. Wilson DN et al. (1997) Results of a phase I clinical trial of T cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T cell receptor utilization in CSF cell populations. J Neuroimmunol 76:15 - 28.
57. Gold SP et al (1997) Results of a phase I clinical trial of T cell receptor peptide vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T cell populations before and after vaccination with a TCRVβ6 CDR2 peptide. J Neuroimmunol 76: 29 - 38.
58. Waisman A et al. (1996) Suppressive vaccination with DNA encoding a variable region gene of the T cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nature Med 2: 899 - 904.
59. Elliott A et al. (1996) Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J Clin Invest 98: 1602 - 1612.
60. Shaw MK et al. (1997) Local delivery of interleukin 4 by retrovirus transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med 185: 1711 - 1714.
61. Mathisen PM et al. (1997) Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J Exp Med 186: 159 - 164.
62. Miller DH et al. (1996) Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neural 39: 6 - 16.
63. Truyen L et al. (1996) Accumulation of hypointense lesions (black holes) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neural 47: 1469 - 1476.
64. Chofflon M et al. (1992) Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis. Eur Cyt Netw 3: 523 - 531.
65. Dore-Duffy P et al. (1994) Circulating soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: Correlation with clinical activity. Ann Neural 37: 55 - 62.
66. Giovannoni G et al. (1997) Longitudinal study of soluble adhesion molecules in multiple sclerosis: Correlation with gadolinium enhanced magnetic resonance imaging. Neurol 48: 1557 - 1565.
67. Chou YK et al. (1994) T cell receptor Vbeta gene usage in the recognition of myelin basic protein by cerebrospinal fluid and blood derived T cells from patients with multiple sclerosis. J Neurosc Res 37: 169 - 181.
68. Soderstrom M et al. (1993) T cells recognizing multiple peptides of myelin basic protein are found in blood and enriched in cerebrospinal fluid in optic neuritis and multiple sclerosis. Scand J Immunol 37: 355 - 368.
69. Utz U et al. (1994) Heterogeneity of T cell receptor alpha chain complementary detemining region 3 in myelin basic protein specific T cells increases with severity of multiple sclerosis. Proc Natl Acad Sci USA 91: 5567 - 5571.
70. Weiner BL et al. (1993) Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259: 1321 - 1263.